478 related articles for article (PubMed ID: 2421862)
1. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
Ginsberg J; von Westarp C
CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
[TBL] [Abstract][Full Text] [Related]
2. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
3. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
5. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
Gupta MK
Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
[TBL] [Abstract][Full Text] [Related]
7. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
8. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
[TBL] [Abstract][Full Text] [Related]
9. Thyroid stimulating immunoglobulin in Graves' disease.
Luttrell BM; Hales IB
Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
[TBL] [Abstract][Full Text] [Related]
10. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
12. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
[TBL] [Abstract][Full Text] [Related]
14. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
15. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
16. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
[TBL] [Abstract][Full Text] [Related]
17. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
[No Abstract] [Full Text] [Related]
18. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
Creagh FM; Howells RD; Williams S; Didcote S; Hashim FA; Petersen VB; Rees Smith B
Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
[TBL] [Abstract][Full Text] [Related]
19. [Autoantibodies against TSH-receptor in Graves' disease (author's transl)].
Shishiba Y
Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1567-72. PubMed ID: 6262419
[No Abstract] [Full Text] [Related]
20. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].
Shishiba Y
Nihon Rinsho; 1983; 41(4):801-7. PubMed ID: 6310180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
